¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific capsular reaction"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
age-specific rate
¿¬·Éº°ºñÀ²
cause-specific rate
¿øÀκ°ºñÀ²
donor-specific phage
Á¦°øÀÚÆ¯ÀÌÆÄÁö, °ø¿©ÀÚÆ¯ÀÌÆÄÁö
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific
±ºÆ¯ÀÌ-
group-specific antigen
¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
neuron-specific enolase
´º·±Æ¯ÀÌ¿¡³î¶ó¾ÆÁ¦
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
prostate specific antigen
Àü¸³»ùƯÀÌÇ׿ø
species-specific
Á¾Æ¯ÀÌ-
species-specific antigen
Á¾Æ¯ÀÌÇ׿ø
species-specific reactivity
Á¾Æ¯À̹ÝÀÀ¼º
specific
1. ƯÀÌ-, ƯÁ¤- 2. Á¾-
specific absorption rate
ºñÈí¼öÀ²
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
chain reaction
¿¬¼â¹ÝÀÀ
complement fixation reaction
µµ¿òü°áÇÕ¹ÝÀÀ, º¸Ã¼°áÇÕ¹ÝÀÀ
cross reaction
±³Â÷¹ÝÀÀ
delayed reaction
Áö¿¬¹ÝÀÀ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
inhibition reaction
¾ïÁ¦¹ÝÀÀ
initial reaction
Ãʱâ¹ÝÀÀ
late reaction
(¢¡delayed reaction) Áö¿¬¹ÝÀÀ
periosteal reaction
»À¸·¹ÝÀÀ, °ñ¸·¹ÝÀÀ
phobic reaction
°øÆ÷¹ÝÀÀ
polymerase chain reaction
ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
pyrogenic reaction
¹ß¿¹ÝÀÀ
rejection reaction
°ÅºÎ¹ÝÀÀ
reversible reaction
°¡¿ª¹ÝÀÀ
second order reaction
ÀÌÂ÷¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
age-specific fertility rate
¿¬·Éº°Ãâ»êÀ²
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific action
ƯÀÌÀÛ¿ë
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific antagonist
ƯÀÌ´ëÇ×Á¦
specific antigen
ƯÀÌÇ׿ø
specific pathogen free animal
ƯÁ¤¹«º´¿øÃ¼µ¿¹°
type specific antigen
ÇüƯÀÌÇ׿ø
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú
cause-specific rate
¿øÀκ°Æ¯¼öÀ²
specific charge
°ßÁÜÀüÇÏ, ºñÀüÇÏ
specific compliance
ƯÀÌź¼º, ƯÀÌÀ¯¼øµµ, ƯÀÌÀÀ¶ô
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
group-specific antigen
±º-ƯÀÌÇ׿ø
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immunity, specific
ƯÀ̸鿪
platelet-specific antigens
Ç÷¼ÒÆÇƯÀÌÇ׿ø
pneumococcal [specific] polysaccharide
Æó·Å±¸±Õ(ƯÀÌ)´Ù´ç·ù
polysaccharide, pneumococcal [specific]
Æó·Å±¸±Õ(ƯÀÌ)´Ù´ç·ù
prostate specific antigen
Àü¸³¼±Æ¯ÀÌÇ׿ø
prostate-specific antigen
Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
prostatic specific antigen
Àü¸³¼± ƯÀÌÇ׿ø
ADR : adverse drug reaction
¾à¹°À¯ÇØÀÛ¿ë(å·ÚªêóúªíÂéÄ).
Arthuss reaction
¾Æ¸£Åõ½º¹ÝÀÀ
Cannizzaros reaction
Ä«´ÏÂ¥·Î¹ÝÀÀ.
Chediaks reaction
¼¼µð¾ÆÅ© ¹ÝÀÀ.
Dische reaction
µð½¬¹ÝÀÀ.
Ehrlich reaction
¿¡¸£¸®È÷ ¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
capsular hemiplegia
³»Æ÷¼º Æí¸¶ºñ(Ò®øÐàõø¶Ø«Ýö).
capsular insufficiency =hypoepinephry
ºÎ½Å±â´ÉºÎÀü(ÜùãìѦÒöÝÕîï).
capsular ligament
ÇǸ·Àδë(¡ìåÓá).
capsular ligaments
°üÀýÁÖ¸Ó´ÏÀδë
capsular lumen
ÁָӴϰø°£
capsular mesenchyme
ÇǸ·Áß°£¿±
capsular paralysis
³»Æ÷¼º ¸¶ºñ(¡Ø«Ýö).
capsular placenta
ÇÇÆ÷Å»¶ô¸·Å¹Ý(ù¬øÐ÷ժد÷ÃÚï).
capsular polysaccharide
Çù¸·´Ù´ç·ù
capsular polysaccharide
Çù¸·¼º ´Ù´çÁú(¡àõÒýÓØòõ), ĸ½¶´Ù´çÁú.
capsular pseudocirrhosis
ÇǸ·¼º °¡¼º°æº¯(¡àõÊ£àõÌãܨ).
capsular space
ÇǸ·¼º °ø°£(ù¬Ø¯àõÍöÊà), °üÀý³¶ °£°Ý.[Á¤Çü]°üÀý³¶°(μï½Ò¥Ë·).
capsular space
°üÀý³¶°£°Ý.Á¤Çü°üÀý³¶°(μï½Ò¥Ë·).
capsular staining
Çù¸·¿°»ö
capsular vein
ÇǸ·Á¤¸Æ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½